Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedA new revision tag v3.6.6 was added and the previous tag v3.6.5 was removed. This indicates a small update to the page's revision history and metadata.SummaryDifference0.0%

- Check9 days agoChange DetectedAn NIH grant/contract identifier (2015) was added to the study's identifiers section. This links the trial to its funding source and improves record completeness.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision label on the page updated from v3.6.4 to v3.6.5. This indicates a new revision of the page, representing an internal version update rather than a substantive content change.SummaryDifference0.0%

- Check31 days agoChange DetectedRemoved the disease label Multiple myeloma and the related topics MedlinePlus Genetics from the study page. This changes how the study is categorized and what related topics are suggested to users.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a minor platform update. It does not alter the study details or data presented on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now lists 'Multiple myeloma' as a topic and adds 'MedlinePlus Genetics' as a related topic under related topics.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.